Ignite Creation Date:
2024-05-06 @ 1:58 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04177316
Status:
COMPLETED
Last Update Posted:
2019-11-26
First Post:
2019-11-22
Brief Title:
Hypermethylation of VTRNA2-1 Promoter in HCC Outcome
Sponsor:
Chang Gung Memorial Hospital
Organization:
Chang Gung Memorial Hospital
Study Overview
Official Title:
Differential Hypermethylation Status of the VTRNA2-1 Promoter in Hepatocellular Carcinoma as an Independent Factor After Partial Hepatectomy
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The clinic-pathological data were retrieved from the cancer registry database from the Cancer Center of Chang Gung Memorial Hospital Linkou branch Of the 92 HCC patients with partial hepatectomies enrolled The biological specimen was studied with approval
Detailed Description:
This study was approved by the Institute Review Board IRB of Chang Gung Memorial Hospital Linkou Branch IRB 201801969B0 The clinic-pathological data were retrieved from the cancer registry database from the Cancer Center of Chang Gung Memorial Hospital Linkou branch Of the 92 HCC patients with partial hepatectomies enrolled all patients had curative hepatectomy and those with different cancers were excluded HCC tumor tissue and normal tissue 3 cm from the tumor margin were stored immediately in a -80 degree freezer at the Central Biobank of Chang Gung Memorial Hospital The personal information was protected with decoding and registered with number
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None